FPH Statistics

Total Valuation

Fisher & Paykel Healthcare Corporation has a market cap or net worth of NZD 21.96 billion. The enterprise value is 22.06 billion.

Market Cap	21.96B
Enterprise Value	22.06B

Important Dates

The next estimated earnings date is Thursday, September 5, 2024.

Earnings Date	Sep 5, 2024
Ex-Dividend Date	Jun 26, 2024

Share Statistics

Fisher & Paykel Healthcare Corporation has 585.96 million shares outstanding. The number of shares has increased by 0.78% in one year.

Shares Outstanding	585.96M
Shares Change (YoY)	+0.78%
Shares Change (QoQ)	+0.56%
Owned by Insiders (%)	0.39%
Owned by Institutions (%)	55.53%
Float	583.66M

Valuation Ratios

The trailing PE ratio is 165.80 and the forward PE ratio is 61.70. Fisher & Paykel Healthcare Corporation's PEG ratio is 2.75.

PE Ratio	165.80
Forward PE	61.70
PS Ratio	12.51
PB Ratio	12.43
P/FCF Ratio	194.65
PEG Ratio	2.75

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 47.70, with an EV/FCF ratio of 195.60.

EV / Earnings	166.39
EV / Sales	12.66
EV / EBITDA	47.70
EV / EBIT	62.43
EV / FCF	195.60

Financial Position

The company has a current ratio of 1.83, with a Debt / Equity ratio of 10.75.

Current Ratio	1.83
Quick Ratio	0.90
Debt / Equity	10.75
Debt / EBITDA	0.41
Debt / FCF	1.68
Interest Coverage	19.42

Financial Efficiency

Return on equity (ROE) is 7.55% and return on invested capital (ROIC) is 11.48%.

Return on Equity (ROE)	7.55%
Return on Assets (ROA)	9.85%
Return on Capital (ROIC)	11.48%
Revenue Per Employee	248,794
Profits Per Employee	18,929
Employee Count	7,031
Asset Turnover	0.78
Inventory Turnover	2.04

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +66.24% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+66.24%
50-Day Moving Average	32.49
200-Day Moving Average	27.39
Relative Strength Index (RSI)	72.25
Average Volume (20 Days)	440,640

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Fisher & Paykel Healthcare Corporation had revenue of NZD 1.74 billion and earned 132.60 million in profits. Earnings per share was 0.23.

Revenue	1.74B
Gross Profit	1.04B
Operating Income	353.40M
Pretax Income	235.70M
Net Income	132.60M
EBITDA	444.80M
EBIT	353.40M
Earnings Per Share (EPS)	0.23

Full Income Statement

Balance Sheet

The company has 82.00 million in cash and 189.10 million in debt, giving a net cash position of -107.10 million or -0.18 per share.

Cash & Cash Equivalents	82.00M
Total Debt	189.10M
Net Cash	-107.10M
Net Cash Per Share	-0.18
Equity (Book Value)	1.76B
Book Value Per Share	3.01
Working Capital	319.90M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 429.60 million and capital expenditures -316.80 million, giving a free cash flow of 112.80 million.

Operating Cash Flow	429.60M
Capital Expenditures	-316.80M
Free Cash Flow	112.80M
FCF Per Share	0.19

Full Cash Flow Statement

Margins

Gross margin is 59.93%, with operating and profit margins of 20.28% and 7.61%.

Gross Margin	59.93%
Operating Margin	20.28%
Pretax Margin	13.52%
Profit Margin	7.61%
EBITDA Margin	25.52%
EBIT Margin	20.28%
FCF Margin	6.47%

Dividends & Yields

This stock pays an annual dividend of 0.42, which amounts to a dividend yield of 1.12%.

Dividend Per Share	0.42
Dividend Yield	1.12%
Dividend Growth (YoY)	2.47%
Years of Dividend Growth	11
Payout Ratio	89.97%
Buyback Yield	-0.78%
Shareholder Yield	0.34%
Earnings Yield	0.60%
FCF Yield	0.51%

Dividend Details

Stock Splits

The last stock split was on October 4, 2004. It was a forward split with a ratio of 5.

Last Split Date	Oct 4, 2004
Split Type	Forward
Split Ratio	5